| Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide … A Lievre, A Turpin, I Ray-Coquard, K Le Malicot, J Thariat, G Ahle, ... European Journal of Cancer 141, 62-81, 2020 | 148 | 2020 |
| Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives GS Roth, T Decaens European Journal of Cancer 87, 101-112, 2017 | 67 | 2017 |
| GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions S Brun, E Bestion, E Raymond, F Bassissi, ZM Jilkova, S Mezouar, ... Autophagy 18 (3), 678-694, 2022 | 41 | 2022 |
| Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma ZM Jilkova, AZ Kuyucu, K Kurma, STA Pour, GS Roth, G Abbadessa, Y Yu, ... Oncotarget 9 (13), 11145, 2018 | 40 | 2018 |
| Targeting Akt in hepatocellular carcinoma and its tumor microenvironment M Mroweh, G Roth, T Decaens, PN Marche, H Lerat, Z Macek Jílková International Journal of Molecular Sciences 22 (4), 1794, 2021 | 33 | 2021 |
| Percutaneous ablation-induced immunomodulation in hepatocellular carcinoma L Dumolard, J Ghelfi, G Roth, T Decaens, Z Macek Jilkova International journal of molecular sciences 21 (12), 4398, 2020 | 33 | 2020 |
| Hepatocellular carcinoma: French intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD … JF Blanc, A Debaillon-Vesque, G Roth, JC Barbare, AS Baumann, ... Clinics and Research in Hepatology and Gastroenterology 45 (2), 101590, 2021 | 30 | 2021 |
| Efficacy of AKT inhibitor ARQ 092 compared with sorafenib in a cirrhotic rat model with hepatocellular carcinoma GS Roth, Z Macek Jilkova, A Zeybek Kuyucu, K Kurma, ST Ahmad Pour, ... Molecular Cancer Therapeutics 16 (10), 2157-2165, 2017 | 29 | 2017 |
| Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine? GS Roth, C Neuzillet, M Sarabi, J Edeline, D Malka, A Lièvre European Journal of Cancer 179, 1-14, 2023 | 19 | 2023 |
| Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: a French comprehensive multicentre ambispective observational cohort … M Brugel, L Letrillart, C Evrard, A Thierry, D Tougeron, M El Amrani, ... European Journal of Cancer 166, 8-20, 2022 | 19 | 2022 |
| Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma GS Roth, Y Teyssier, M Abousalihac, A Seigneurin, J Ghelfi, C Sengel, ... World Journal of Gastroenterology 26 (3), 324, 2020 | 19 | 2020 |
| Hypoxia drives dihydropyrimidine dehydrogenase expression in macrophages and confers chemoresistance in colorectal cancer M Malier, K Gharzeddine, MH Laverriere, S Marsili, F Thomas, M Court, ... Cancer Research 81 (23), 5963-5976, 2021 | 18 | 2021 |
| Gemcitabine/nab-paclitaxel versus FOLFIRINOX in locally advanced pancreatic cancer: A European multicenter study N Williet, A Petrillo, G Roth, M Ghidini, M Petrova, J Forestier, A Lopez, ... Cancers 13 (11), 2797, 2021 | 18 | 2021 |
| LBA77 5-fluorouracil and oxaliplatin with or without docetaxel in the first-line treatment of HER2 negative locally advanced (LA) unresectable or metastatic gastric or gastro … A Zaanan, O Bouche, C De La Fouchardiere, E Samalin-Scalzi, ... Annals of Oncology 34, S1318, 2023 | 17 | 2023 |
| Lysine methylation signaling in pancreatic cancer GS Roth, AG Casanova, N Lemonnier, N Reynoird Current Opinion in Oncology 30 (1), 30-37, 2018 | 16 | 2018 |
| Performance of bile aspiration plus brushing to diagnose malignant biliary strictures during endoscopic retrograde cholangiopancreatography GS Roth, P Bichard, M Fior-Gozlan, H Roth, J Auroux, O Risse, ... Endoscopy International Open 4 (09), E997-E1003, 2016 | 16 | 2016 |
| Smyd3 impedes small cell lung cancer sensitivity to alkylation damage through rnf113a methylation–phosphorylation cross-talk V Lukinović, S Hausmann, GS Roth, C Oyeniran, T Ahmad, N Tsao, ... Cancer discovery 12 (9), 2158-2179, 2022 | 15 | 2022 |
| Comparison of trans-arterial chemoembolization and bland embolization for the treatment of hepatocellular carcinoma: a propensity score analysis GS Roth, M Benhamou, Y Teyssier, A Seigneurin, M Abousalihac, ... Cancers 13 (4), 812, 2021 | 15 | 2021 |
| Lysine methyltransferases signaling: histones are just the tip of the iceberg V Lukinović, AG Casanova, GS Roth, F Chuffart, N Reynoird Current Protein and Peptide Science 21 (7), 655-674, 2020 | 15 | 2020 |
| Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? GS Roth, F Villeret, T Decaens, P Merle, P Nahon Liver International 43 (3), 546-557, 2023 | 13 | 2023 |
